USPTO 2015–2025 USPTO PatentsView US Corporation

Amyris, Inc.

USPTO PatentsView assignee record — 74 granted patents across 38 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

74
Total patents granted
38
CPC technology areas
20.3
Avg claims per patent
+39%
5-year filing velocity

The verdict

Amyris holds 74 US patents across 38 technology areas — rank #4,699 of 50,000 tracked assignees.

#4,699
of 50,000 US assignees by volume
Top 6%
by Innovation Score (56.3/100)
20.3
avg claims per patent
+39%
filing velocity, last 5 yrs

Portfolio overview

AMYRIS, INC. has been granted 74 US utility patents between 2015 and 2025, placing AMYRIS, INC. at rank #4,699 across all assignees tracked by PlainPatent. This portfolio spans 38 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.3 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, AMYRIS, INC. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 56.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 43 grants, compared with 31 in the 2015–2019 window — a +39% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. AMYRIS, INC.'s 20.3 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 38 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark AMYRIS, INC. against peers pursuing similar technology classes.

How does AMYRIS compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows AMYRIS holds 74 patents — placing it at rank #4,699 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

AMYRIS's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

56 Top 6% higher than 94% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

24681012 20152016201720182019202020212022202320242025 8
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
AMYRIS, INC. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 5.4%
2016 5 6.8%
2017 10 13.5%
2018 9 12.2%
2019 3 4.1%
2020 8 10.8%
2021 7 9.5%
2022 7 9.5%
2023 4 5.4%
2024 9 12.2%
2025 8 10.8%

Which technologies does AMYRIS, INC. patent most?

Top 15 of 38 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Complex
Velocity Growing

Where it ranks

Overall rank by patents

#4,699

Across all tracked assignees

Innovation Score

56.3 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does AMYRIS, INC. hold?
AMYRIS, INC. holds 74 US granted patents filed between 2015 and 2025, spanning 38 technology areas.
What is AMYRIS, INC.'s Innovation Score?
AMYRIS, INC. has an Innovation Score of 56.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does AMYRIS, INC. focus on?
AMYRIS, INC.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 39 patents. The company has filed patents in 38 CPC subclasses total.
Is AMYRIS, INC.'s patent filing rate increasing or decreasing?
AMYRIS, INC.'s recent filing velocity is +39% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for AMYRIS, INC.'s patents?
AMYRIS, INC.'s patents average 20.3 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the AMYRIS, INC. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

Amyris's 74 grants land it in the top 6% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Amyris ranks #4,699 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in C12N — see who else leads that technology area. C12N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov